ESR 1 promoter hypermethylation does not predict atypia in random periareolar fine needle aspiration nor persistent atypia after 12 months tamoxifen chemoprevention

Seewaldt, V., Baker, J., Bean, G., Lem, S., Goldenberg, V., Rowell, C., Iharra-Drendall, C., Ostrander, J., Grant, T., Pilie, P., Vasilatos, S., Troch, M., Scott, V., Wilke, L., Paisie, C., Rahiner, S., Tores, A., Zalles, C., & Broadwater, G. (2008). ESR 1 promoter hypermethylation does not predict atypia in random periareolar fine needle aspiration nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiology, Biomarkers and Prevention, 17(8), 1884 - 1890.